FAT Brands Inc. (FAT)
NASDAQ: FAT · Real-Time Price · USD
2.210
-0.070 (-3.07%)
At close: Aug 1, 2025, 4:00 PM
2.230
+0.020 (0.90%)
After-hours: Aug 1, 2025, 5:40 PM EDT
CTI BioPharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CTI BioPharma stock has a target of 10, which predicts a 352.49% increase from the current stock price of 2.21.
Price Target: $10.00 (+352.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for CTI BioPharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Loop Capital | Loop Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +352.49% | May 12, 2025 |
| Loop Capital | Loop Capital | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +442.99% | Mar 4, 2025 |
| Loop Capital | Loop Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +578.73% | Jul 26, 2023 |
Financial Forecast
Revenue This Year
590.24M
from 592.65M
Decreased by -0.41%
Revenue Next Year
641.50M
from 590.24M
Increased by 8.68%
EPS This Year
-8.81
from -11.60
EPS Next Year
-7.11
from -8.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 620.0M | 681.5M |
| Avg | 590.2M | 641.5M |
| Low | 566.7M | 608.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 4.6% | 15.5% |
| Avg | -0.4% | 8.7% |
| Low | -4.4% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -7.90 | -6.49 |
| Avg | -8.81 | -7.11 |
| Low | -9.72 | -7.73 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.